The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 214 results:
Author Title [ Type(Desc)] Year
Filters: Author is Liakopoulos, Vassilios  [Clear All Filters]
Journal Article
Eleftheriadis, T., Pissas G., Sounidaki M., Antoniadi G., Tsialtas I., Liakopoulos V., et al. (2017).  Urate crystals directly activate the T-cell receptor complex and induce T-cell proliferation.. Biomed Rep. 7(4), 365-369.
Eleftheriadis, T., Pissas G., Antoniadi G., Filippidis G., Liakopoulos V., & Stefanidis I. (2020).  Urate crystals trigger B-cell receptor signal transduction and induce B-cell proliferation.. J Basic Clin Physiol Pharmacol. 31(4), 
Eleftheriadis, T., Pissas G., Liakopoulos V., & Stefanidis I. (2018).  Uric acid and cellular and humoral alloimmunity.. J Heart Lung Transplant. 37(11), 1388.
Leivaditis, K., Panagoutsos S., Roumeliotis A., Liakopoulos V., & Vargemezis V. (2014).  Vascular access for hemodialysis: postoperative evaluation and function monitoring.. Int Urol Nephrol. 46(2), 403-9.
Roumeliotis, S., Dounousi E., Salmas M., Eleftheriadis T., & Liakopoulos V. (2020).  Vascular Calcification in Chronic Kidney Disease: The Role of Vitamin K- Dependent Matrix Gla Protein.. Front Med (Lausanne). 7, 154.
Peppa, V. I., Arsenopoulou Z. V., Zarogiannis S. G., Deligiorgi T., Jagirdar R., Makantasis I., et al. (2014).  VEGF increases the permeability of sheep pleura ex vivo through VEGFR2 stimulation.. Cytokine. 69(2), 284-8.
Eleftheriadis, T., Antoniadi G., Liakopoulos V., Antoniadis N., Stefanidis I., & Galaktidou G. (2010).  Vitamin D receptor activators and response to injury in kidney diseases.. J Nephrol. 23(5), 514-24.
Roumeliotis, S., Roumeliotis A., Dounousi E., Eleftheriadis T., & Liakopoulos V. (2020).  Vitamin K for the treatment of cardiovascular disease in End-Stage Renal Disease patients: is there hope?. Curr Vasc Pharmacol.
Roumeliotis, S., Roumeliotis A., Georgianos P. I., Thodis E., Schurgers L. J., Maresz K., et al. (2022).  VItamin K In PEritonial DIAlysis (VIKIPEDIA): Rationale and study protocol for a randomized controlled trial.. PLoS One. 17(8), e0273102.
Papakonstantinou, E., Pikilidou M., Georgianos P., Yavropoulou M., Tsivgoulis G., Hadjistavri L., et al. (2020).  Wave reflections and systemic vascular resistance are stronger determinants of pulse pressure amplification than aortic stiffness in drug-naïve hypertensives.. Clin Exp Hypertens. 42(3), 287-293.
Sarafidis, P. A., Loutradis C., Mayer C. C., Karpetas A., Pagkopoulou E., Bikos A., et al. (2019).  Weak within-individual association of blood pressure and pulse wave velocity in hemodialysis is related to adverse outcomes.. J Hypertens. 37(11), 2200-2208.
Georgianos, P. I., Papachristou E., & Liakopoulos V. (2023).  Which blood pressure threshold indicates a therapeutic benefit for patients with chronic kidney disease?. Hypertens Res. 46(4), 890-892.
Eleftheriadis, T., Liakopoulos V., Antoniadi G., & Stefanidis I. (2010).  Which is the best way for estimating transferrin saturation?. Ren Fail. 32(8), 1022-3.
Eleftheriadis, T., Pissas G., Liakopoulos V., & Stefanidis I. (2018).  Xanthine oxidase inhibitors may prevent or slow chronic kidney disease even in the absence of hyperuricemia.. Kidney Int. 94(4), 830-831.

Pages

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.